We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The collaboration aims to support China’s regulator in strengthening their regulatory capacity to improve patient access to safe and high-quality medicines and to promote global health security.
The Medicines and Healthcare products Regulatory Agency is playing a pivotal role helping to ensure that the UK remains one of the best places in the world to deliver safe, cutting-edge research.
Pharmacists Dean Dookhan and Narvinder Nandra diverted hundreds of thousands of doses of prescription medicines, controlled as Class C drugs, from the legal supply chain onto the black market.
Progestogen-only contraceptive pills will be available for the first time from pharmacies without prescription, increasing choice for women in the ways in which they can access contraception.
UK Life Sciences Vision sets 10-year strategy for sector to solve some of the biggest healthcare problems of our generation, including cancer and dementia.
First published during the 2019 to 2022 Johnson Conservative government
The Medicines and Healthcare products Regulatory Agency (MHRA) and Health Canada have published guidance to improve the safety of patients in clinical trials through improved quality of the periodic safety reports known as D…
Putting patients first: A new era for our agency
The Prime Minister was able to see first-hand the pivotal role NIBSC has played in getting safe and effective COVID-19 vaccines to the UK public during the pandemic.
Information for the public about lateral flow devices (LFDs) provided by NHS Test and Trace
Patients should not stop any treatments without consulting their doctor or pharmacist
Batch Number 1K10121 has been found to potentially have the wrong amount of active ingredients
Operation Pangea - Officers from the Medicines and Healthcare products Regulatory Agency (MHRA) have seized millions of illegally traded medicines and medical devices.
This follows a rigorous review of the safety, quality and effectiveness of the vaccine in this age group.
A personal trainer was sentenced today to 31 months in jail for selling and supplying unlicensed and prescription medicines, together with Anabolic steroids, to the public.
The vaccine has been approved after meeting the required safety, quality and effectiveness standards.
Change approved following detailed review of additional stability data
The public has until 3 June to respond to the consultation on the potential reclassification of Nuromol to a general sale list medicine.
Statement from Dr June Raine, MHRA Chief Executive, following the Joint Committee on Vaccination and Immunisation's new advice
UK medicines regulator issues its first authorisation under Project Orbis for Osimertinib (Tagrisso), a post-surgery treatment for lung cancer.
Dr Alison Cave joins the Medicines and Healthcare products Regulatory Agency (MHRA) as Chief Safety Officer
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).